Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Frequency Therapeutics Inc (NQ: FREQ )

0.4373 -0.0077 (-1.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 369,995
Open 0.4122
Bid (Size) 0.4111 (25)
Ask (Size) 0.4600 (2)
Prev. Close 0.4450
Today's Range 0.4122 - 0.4395
52wk Range 0.4120 - 5.590
Shares Outstanding 35,286,837
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
 
Via Benzinga
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire

Performance

YTD
-88.93%
-88.93%
1 Month
-33.83%
-33.83%
3 Month
-83.05%
-83.05%
6 Month
-75.97%
-75.97%
1 Year
-79.85%
-79.85%

More News

Read More
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
From Frequency Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
Via Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
Via Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge
Via Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
Via Benzinga
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
From Frequency Therapeutics
Via Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics to Host Virtual Investor Event, Highlighting Hearing Restoration Candidate FX-322 in Advance of Q1 Clinical Results
From Frequency Therapeutics, Inc.
Via Business Wire
Frequency Therapeutics Provides Business Updates and Third Quarter 2022 Financial Results
From Frequency Therapeutics, Inc.
Via Business Wire
Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.